Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons IncfiledCriticalSquibb & Sons Inc
Publication of MX16514ApublicationCriticalpatent/MX16514A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members
(AREA)
Abstract
Se exhibe vasolidadora, por compuestos que tienen la formula.en donde x puede ser -s- o -ch2-; y la presente a una continuacion -en- parte de la solicitud de los E.U.A. No. de serie 208,521, la presentada en junio 20,1988.Vasolidator is exhibited, by compounds that have the formula. Where x can be -s- or -ch2-; and submit it to a continuation-in-part of the U.S. request. Serial No. 208,521, the one filed on June 20,1988.
MX1651489A1988-06-201989-06-19
PROCEDURE FOR THE PREPARATION OF BENZAZEPINE AND BENZOTIAZEPINE DERIVATIVES.
MX16514A
(en)
1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT